Effexor XR: Advanced SNRI Therapy for Sustained Mood Stabilization
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.49 | $44.72 (0%) | 🛒 Add to cart |
| 60 | $1.09 | $89.44 $65.36 (27%) | 🛒 Add to cart |
| 90 | $0.95 | $134.16 $85.14 (37%) | 🛒 Add to cart |
| 120 | $0.88 | $178.88 $105.78 (41%) | 🛒 Add to cart |
| 180 | $0.81 | $268.32 $145.34 (46%) | 🛒 Add to cart |
| 270 | $0.77 | $402.48 $207.26 (49%) | 🛒 Add to cart |
| 360 | $0.74
Best per pill | $536.64 $266.60 (50%) | 🛒 Add to cart |
| Product dosage: 75mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.35 | $40.42 (0%) | 🛒 Add to cart |
| 60 | $0.95 | $80.84 $56.76 (30%) | 🛒 Add to cart |
| 90 | $0.80 | $121.26 $72.24 (40%) | 🛒 Add to cart |
| 120 | $0.75 | $161.68 $89.44 (45%) | 🛒 Add to cart |
| 180 | $0.67 | $242.52 $121.26 (50%) | 🛒 Add to cart |
| 270 | $0.62 | $363.78 $167.70 (54%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $485.04 $217.58 (55%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Effexor XR (venlafaxine hydrochloride extended-release) is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), designed for the management of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. Its extended-release formulation ensures consistent plasma concentrations over 24 hours, supporting stable therapeutic effects and minimizing peak-trough fluctuations associated with immediate-release formulations. By modulating key neurotransmitters implicated in mood and anxiety regulation, Effexor XR offers a clinically validated option for long-term psychiatric care under professional supervision.
Features
- Contains venlafaxine hydrochloride as the active ingredient
- Extended-release capsule formulation for once-daily dosing
- Available in 37.5 mg, 75 mg, and 150 mg strengths
- Designed for gradual release to maintain steady-state concentration
- FDA-approved for MDD, GAD, SAD, and panic disorder
- Requires prescription and medical oversight
Benefits
- Provides dual reuptake inhibition of serotonin and norepinephrine for comprehensive neuromodulation
- Supports sustained mood elevation and reduction in anxiety symptoms over time
- Minimizes dosing frequency with 24-hour extended-release delivery
- May improve overall daily functioning and quality of life in appropriate patients
- Offers flexibility in dosing titration based on individual therapeutic response and tolerability
Common use
Effexor XR is indicated for the treatment of major depressive disorder in adults, generalized anxiety disorder, social anxiety disorder, and panic disorder with or without agoraphobia. It is used as part of a comprehensive treatment plan that may include psychotherapy, lifestyle modifications, and other interventions tailored to the patient’s clinical profile.
Dosage and direction
The recommended starting dose for most adults is 75 mg once daily, taken with food at approximately the same time each day. Depending on therapeutic response and tolerability, dosage may be increased in increments of up to 75 mg per day at intervals of no less than 4 days, up to a maximum of 225 mg per day for depression, and 225 mg for anxiety disorders. Capsules should be swallowed whole and not crushed, chewed, or placed in water. Dosage adjustments are necessary in patients with hepatic or renal impairment.
Precautions
- Monitor for emergence of anxiety, panic attacks, insomnia, irritability, hostility, impulsivity, and suicidality, especially during early treatment and dose adjustments
- Use with caution in patients with a history of mania, seizures, or angle-closure glaucoma
- May increase blood pressure; regular monitoring advised
- Discontinuation should be gradual to avoid withdrawal symptoms
- Not recommended during pregnancy unless potential benefit justifies potential risk
Contraindications
- Hypersensitivity to venlafaxine or any component of the formulation
- Concurrent use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy
- Use of MAOIs within 7 days after discontinuing Effexor XR
Possible side effect
Common adverse reactions include nausea, headache, drowsiness, dry mouth, dizziness, insomnia, constipation, sweating, and nervousness. Less frequently, patients may experience increased blood pressure, blurred vision, abnormal dreams, weight changes, sexual dysfunction, or serotonin syndrome. Severe side effects may include clinical worsening of depression, suicidal thoughts, seizures, or angle-closure glaucoma.
Drug interaction
- Serotonin syndrome risk with other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, tramadol)
- Increased bleeding risk with NSAIDs, aspirin, warfarin
- Potential interaction with CYP2D6 inhibitors (e.g., quinidine)
- Avoid use with MAOIs due to risk of hypertensive crisis
- May interact with drugs that affect hepatic metabolism
Missed dose
If a dose is missed, take it as soon as remembered unless it is close to the time of the next dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure stable therapeutic levels.
Overdose
Symptoms of overdose may include dizziness, sedation, tachycardia, changes in ECG intervals, seizures, or serotonin syndrome. Management involves supportive care, gastric lavage if presented early, and activated charcoal. There is no specific antidote; monitor vital signs and provide symptomatic treatment.
Storage
Store at room temperature (20–25°C or 68–77°F), in a dry place, away from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual responses to Effexor XR may vary.
Reviews
Clinical studies and patient reports indicate that Effexor XR is effective in reducing symptoms of depression and anxiety for many individuals. Some users note improved mood stability and daily functioning, while others report side effects such as initial nausea or sleep disturbances. Long-term adherence often correlates with personalized dosing and ongoing medical supervision.